Kymera Therapeutics Inc (NASDAQ:KYMR) traded at $43.58 at close of the session on Tuesday, June 03 and made an upward move of 1.04% on its previous day’s price. Kymera Therapeutics Inc has a market cap of $2.84 billion and is expected to release its quarterly
Kymera Therapeutics Inc (NASDAQ:KYMR) shares, rose in value on Friday, May 30, with the stock price down by -2.02% to the previous day’s close as strong demand from buyers drove the stock to $29.64. Actively observing the price movement in the last trading, the stock
Kymera Therapeutics Inc (NASDAQ:KYMR) shares, rose in value on Friday, May 09, with the stock price down by -2.27% to the previous day’s close as strong demand from buyers drove the stock to $30.07. Actively observing the price movement in the last trading, the stock
Kymera Therapeutics Inc (NASDAQ:KYMR) concluded the trading at $33.26 on Friday, April 25 with a fall of -0.89% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $33.56 and 5Y monthly beta
Kymera Therapeutics Inc (NASDAQ:KYMR) concluded the trading at $33.26 on Friday, April 25 with a fall of -0.89% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $33.56 and 5Y monthly beta
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.